SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-002476
Filing Date
2015-08-05
Accepted
2015-08-05 18:41:49
Documents
2
Period of Report
2015-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4331
2 EX-24 DOCUMENT attachment1.htm EX-24 4808
  Complete submission text file 0000899243-15-002476.txt   10625
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Issuer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300 BRISBANE CA 94005
Business Address
Raff Howard V. (Reporting) CIK: 0001648919 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37519 | Film No.: 151030483